Mostrar el registro sencillo del ítem
Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: clinical and biological associations during progression from HG1 to HG3
dc.contributor.author | Ruibal Morell, Alvaro | |
dc.contributor.author | Aguiar Fernández, Pablo | |
dc.contributor.author | Del Río Garma, María del Carmen | |
dc.contributor.author | Arias, José Ignacio | |
dc.contributor.author | Menéndez-Rodríguez, Primitiva | |
dc.contributor.author | Gude Sampedro, Francisco | |
dc.contributor.author | Herranz Carnero, Michel | |
dc.date.accessioned | 2017-06-07T06:52:37Z | |
dc.date.available | 2017-06-07T06:52:37Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 0250-7005 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/133 | |
dc.description.abstract | AIM: To study the clinical and biological (cellular proliferation and hormone-dependence) associations during the progression of histological grade (HG), from HG1 to HG3, in invasive ductal carcinomas of the breast (IDC) <1 cm. PATIENTS AND METHODS: The study group included 119 women with IDCs ≤1 cm, aged between 27 and 88 years (median=61 years). The parameters analyzed were: histological grade (HG1: 52; HG2: 45; HG3: 22); axillary lymph node involvement (N); distant metastasis (M); and immunohistochemical expression of estrogen (ER), progesterone (PR) and androgen (AR) receptors, and Ki67, p53 and B-cell lymphoma 2 (BCL2). RESULTS: Compared to HG3 tumors, HG1s exhibited an increased expression of ER, AR and BCL2, as well as lower expression of p53 and Ki67. In HG1 tumors, significant (p<0.05) associations were found between ER and PR (positive), ER and p53 (negative), ER and Ki67 (negative), PR and AR (positive), PR and p53 (negative), AR and p53 (negative), p53 and BCL2 (negative), and between BCL2 and Ki67 (negative). HG3s only showed significant (p<0.05) associations between ER and Ki-67 (negative) and between BCL2 or Ki-67 (negative). Only two significant relationships (ER-Ki67 and BCL2-Ki67) persisted in all three grades. CONCLUSION: Our results lead us to the following conclusions: i) compared HG1, HG3 ductal carcinomas exhibited decreased expression of ER, AR and BCL2 and increased expression of p53 and Ki67; and ii) only two significant and negative relations (ER-Ki67 and BCL2-Ki67) persisted in all three grades. | |
dc.language.iso | eng | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | androgen receptor | |
dc.subject.mesh | BCL2 | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Breast tumors | |
dc.subject.mesh | Carcinoma, Ductal, Breast | |
dc.subject.mesh | Disease Progression | |
dc.subject.mesh | estrogen receptor | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Ki67 | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Grading | |
dc.subject.mesh | Tumor Burden | |
dc.title | Histological grade (HG) in invasive ductal carcinomas of the breast of less than 1 cm: clinical and biological associations during progression from HG1 to HG3 | |
dc.type | Artigo | es |
dc.authorsophos | Ruibal, Álvaro | |
dc.authorsophos | Aguiar, Pablo | |
dc.authorsophos | Del Rio, María Carmen | |
dc.authorsophos | Arias, José Ignacio | |
dc.authorsophos | Menéndez-Rodríguez, Primitiva | |
dc.authorsophos | Gude, Francisco | |
dc.authorsophos | Herranz, Michel | |
dc.identifier.pmid | 25550604 | |
dc.identifier.sophos | 17687 | |
dc.issue.number | 1 | |
dc.journal.title | ANTICANCER RESEARCH | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Ferrol::Xerencia da Área de Ferrol::Análise clínicos | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Medicina nuclear | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Epidemioloxía Clínica | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago | |
dc.page.initial | 569 | |
dc.page.final | 573 | |
dc.rights.accessRights | openAccess | |
dc.typesophos | Artículo Original | |
dc.volume.number | 35 |